Vanderbilt Ingram Cancer Center

The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies. Read More

Two Vanderbilt-Ingram Cancer Center (VICC) investigators — Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of VICC, and Valerie Jansen, M.D., Ph.D., medical oncology fellow — have received new cancer research grants awarded by Susan G. Komen, the world’s largest nonprofit funder of breast cancer research. Read More

Vanderbilt-Ingram Cancer Center (VICC) has been recognized for the impact of its research programs and excellence in patient care by a panel of National Cancer Institute (NCI) reviewers, receiving an overall “exceptional” score as part of the renewal of the Cancer Center Support Grant (CCSG). Read More

Cancer patients, family members and those who care for cancer patients often need a way to express the deep and often lasting emotions that a cancer diagnosis can bring. Read More

Phila Hach recently celebrated her 89th birthday and she has had much to celebrate over the years. Read More

Health care professionals who care for cancer patients can experience strong emotions with limited opportunities to cope with or express those emotions. During September, Vanderbilt-Ingram Cancer Center and its partners are offering a series of free writing seminars for those health care professionals. Read More

Carlos L. Arteaga, M.D., the Donna S. Hall Professor of Breast Cancer and director of the Center for Cancer Targeted Therapies and the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), has been recognized for his cancer research efforts by the American-Italian Cancer Foundation (AICF). Read More

Cancer affects many families, and patients and their relatives often struggle with an effective way to describe their feelings about the illness and its aftermath. Read More

Anti-cancer drugs are typically tested on one type of cancer at a time. But an international consortium of cancer investigators, including Vanderbilt-Ingram Cancer Center (VICC) researchers, simultaneously tested an existing therapy in patients with several different forms of cancer that all exhibit the same tumor gene mutation. Read More

Jeffrey Rathmell, Ph.D., has been recruited to Vanderbilt University Medical Center (VUMC) to lead a new Center for Immunobiology, a structure supported by the Department of Pathology, Microbiology and Immunology, the Department of Medicine and Vanderbilt-Ingram Cancer Center (VICC). Read More

Vanderbilt-Ingram Cancer Center (VICC) investigators and colleagues at several major medical centers have been testing a new targeted therapy that is showing promise for the treatment of a rare tumor that forms in and around joint cavities. Read More

Dan Brown, M.D., professor of Radiology and Radiological Sciences and chief of Interventional Oncology, will spearhead a national Vanderbilt-led research registry that tracks cancer patients whose tumors are treated with Yttrium-90 (Y-90), a radioactive isotope. Read More

In a town full of amazing singers, Nashville songstress Dawn Sears’ voice was something special. Read More

Marco Davila, M.D., Ph.D., assistant professor of Medicine and of Cancer Biology, has received a grant from the Damon Runyon Cancer Research Foundation that will provide $450,000 over three years to help fund his research on therapies for several types of blood disorders, including various forms of leukemia and non-Hodgkin (also known as non-Hodgkin’s) lymphoma. Read More

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), recently joined other cancer research leaders in a meeting with members of Congress to discuss precision medicine in cancer and the need for continued federal support for cancer research. Read More

The 2015 Annual Meeting of the American Society of Clinical Oncology, held May 29 - June 2 in Chicago, put multiple Vanderbilt-Ingram Cancer Center investigators in the spotlight. Read More

Vanderbilt University Medical Center has again been recognized for a strong and enduring commitment to helping employees and their families live healthy lives. Read More

Pierre Massion, M.D., director of the Thoracic Program and an Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has been recognized for his pioneering work in lung cancer by the LUNGevity Foundation. Read More

A Nashville-based dietitian who lost her mother to cancer is using the power of social media to raise funds for chemo care bags for cancer patients. Read More

Lauren Hackett, MPA, executive director of Administration at Vanderbilt-Ingram Cancer Center (VICC) and chief business officer for Oncology, Imaging and Quantitative Sciences Administration, has been chosen as one of the 2015 Women to Watch by Nashville Medical News. Read More